In today’s video we will do some technical analysis of the stock charts of Valeant Pharmaceuticals (VRX). In the short term the technicals are to the upside with the catalyst being that Bill Ackman of Pershing Square Capital having sold his shares of Valeant.

Long Term the charts are very bearish and will be cut by another 50% in the coming year or two

Video Length – 00:07:49